We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
-11.06%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$309M
Cap. Flow
-$261M
Cap. Flow %
-79.8%
Top 10 Hldgs %
87%
Holding
28
New
1
Increased
4
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.2M
2
WTW icon
Willis Towers Watson
WTW
+$9.08M
3
NOMD icon
Nomad Foods
NOMD
+$3.28M
4
IMPV
Imperva, Inc.
IMPV
+$2.77M
5
CACQ
Caesars Acquisition Company
CACQ
+$705K

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$40.6M
2
ESL
Esterline Technologies
ESL
+$34.2M
3
DBRG icon
DigitalBridge
DBRG
+$27.9M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$27.4M
5
RP
RealPage, Inc.
RP
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 48.09%
2 Financials 15.89%
3 Materials 10.97%
4 Technology 8.96%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNTA
26
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-705,000
Closed -$8.24M
ESL
27
DELISTED
Esterline Technologies
ESL
– –
-450,000
Closed -$34.2M
NRF
28
DELISTED
NorthStar Realty Finance Corp.
NRF
– –
-675,000
Closed -$8.89M
1
2

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM

North Run Capital's Q4 2016 Portfolio in Review

As of Q4 2016, North Run Capital held 28 positions worth $327M, down 49% from $637M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

North Run Capital withdrew a net $261M in Q4 2016, closing 9 positions and reducing 13 holdings. Its most notable exit was Perrigo, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 39% a quarter earlier, followed by Financials and Materials.

Against the trend, North Run Capital opened a new position in Imperva, Inc. worth $2.62M.

  • North Run Capital's largest Q4 2016 buy was Imperva, Inc.: 68,228 shares worth $2.62M.
  • North Run Capital added most to Teva Pharmaceuticals in Q4 2016, an estimated $10.2M increase.
  • North Run Capital's biggest Q4 2016 reduction was DigitalBridge, cutting an estimated $27.9M.
  • North Run Capital fully exited Perrigo in Q4 2016, selling an estimated $40.6M.
  • North Run Capital's ten largest holdings make up 87% of its $327M portfolio in Q4 2016.
  • North Run Capital opened 1 new position and closed 9 in Q4 2016.
  • North Run Capital's portfolio value fell 49% quarter-over-quarter to $327M.

Based on North Run Capital's 13F filing for Q4 2016, filed 10 Feb 2017.